APA aipamena

Petersen, W., Liu, J., Yuan, L., Zhang, H., Schneiderjan, M., Cho, Y., & MacDonald, T. J. (2014). Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283.

Chicago Style aipamena

Petersen, William, Jingbo Liu, Liangping Yuan, Hongying Zhang, Matthew Schneiderjan, Yoon-Jae Cho, and Tobey J. MacDonald. Dasatinib Suppression of Medulloblastoma Survival and Migration Is Markedly Enhanced By Combining Treatment With the Aurora Kinase Inhibitor AT9283. 2014.

MLA aipamena

Petersen, William, et al. Dasatinib Suppression of Medulloblastoma Survival and Migration Is Markedly Enhanced By Combining Treatment With the Aurora Kinase Inhibitor AT9283. 2014.